Home/Healthcare/Diagnostics/Coronary Artery Bypass Grafting Market

Coronary Artery Bypass Grafting Market - Strategic Insights and Forecasts (2026-2031)

Market Size, Share, Forecasts and Trends Analysis By Procedure Type (On-Pump CABG, Off-Pump CABG, Minimally Invasive Direct CABG, Robot-Assisted CABG), By Device Type (Grafts & Conduits, Tissue Stabilizers, Vessel Harvesting Systems, Surgical Instruments, Anastomosis Assistance Devices), By End User (Multi-Specialty Hospitals, Dedicated Cardiac Centers, Ambulatory Surgical Centers), and Geography

$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

πŸ“ž

Your data is secure. We do not share information with any third party.

Coronary Artery Bypass Grafting Market Report

Report IDKSI-008677
PublishedMay 2026
Pages158
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

The Global Coronary Artery Bypass Grafting Market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 5.5%. This growth is expected to lead the market to reach USD 26.4 billion in 2031, up from USD 20.2 billion in 2026, as detailed in the report.

The report analyzes a range of essential devices and systems utilized during bypass grafting procedures. These include graft conduits, vessel harvesting systems, tissue stabilizers, advanced surgical instruments, and robotic surgical assistance platforms, all crucial for restoring myocardial perfusion in patients.

Demand is primarily driven by the increasing prevalence of cardiovascular risk factors globally, such as sedentary lifestyles, metabolic disorders, and aging populations, which elevate coronary artery disease incidence. Additionally, rising diabetes and hypertension prevalence is leading to more patients progressing towards multi-vessel coronary artery disease.

Hospitals are actively expanding their cardiac surgery departments and investing in minimally invasive surgical capabilities to reduce hospitalization duration and post-operative complications. There is also a notable trend toward adopting robot-assisted bypass grafting, which aims to improve bed utilization and reduce post-operative resource dependency.

Regulatory agencies are strengthening procedural quality requirements, as long-term graft patency and surgical complication rates increasingly influence healthcare reimbursement structures. This environment supports the demand for advanced stabilization systems, surgical robotics, and intraoperative imaging technologies that improve procedural precision and standardize surgical outcomes.

Coronary artery bypass grafting holds strategic importance because severe coronary artery disease generates substantial healthcare expenditure through recurrent hospitalizations and cardiac emergencies. Consequently, governments and healthcare systems support cardiac surgery capacity expansion through infrastructure funding, workforce training, and tertiary care modernization initiatives, strengthening procedural accessibility across both developed and emerging economies.

Need data specifically for your business?Request Custom Research β†’

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon